Λεωφ. Αγίου Χρυσοστόμου Σμύρνης 7 Ραφήνα

+30 6932527333

Τηλέφωνο

+30 6932527333

Ωρες Εργασίας

Mon-Sat: 9:00 A.M - 5:00 PM Sun: Closed

Book Appointment

Your perfect smile is a click away!

Παρουσιάσεις σε συνέδρια

  1. E.Moustou, P. Alexandrou, I. Giannopoulou, A. Stratigos, Th. Vergou, S. Masouri, A. Katsampas, Ch. Antoniou “Immunohistochemical lymphatics search in psoriasis”. Posted presentation at the 2nd National Symposium on Research Dermatology, Heraklion Greece, September 30-October 2, 2011
  1. Vergou T, Masouri S, Moustou A, Antoniou C. ” What is the role of stress and thyroid immunity in adult women with acne? ” e-poster to the 22nd Congress of the European Academy of Dermatology and Venereology. 2-6 October 2013,Istanbul.
  1. Clio Dessinioti, Sofia Masouri, Eleni Drakaki, Andreas Katsambas, Christina
  1. Antoniou Short-contact low-dose methyl aminolaevulinate-photodynamic therapy (MAL-PDT) for the treatment of acne vulgaris: a hospital-based case series.

e –poster to the EADV Valencia Spring Symposium 5-8 March 2015

  1. An HLACw6 study in a large Greek population of psoriatic patients and correlation with clinical features of the disease. Hellenic Congress of Dermatology,Thessaloniki.25-28 June ,2015.
  1. Ustekinumab: a successful therapy in psoriasis patients after use of other biologics. Vergou T., Masouri S., Moustou A-E., Antoniou C. 25th EADV Congress,Vienna
  1. Treatment response to biologics agents is not influenced by metabolic syndrome. 13th EADV Spring Symposium .19-22 May 2016
  1. Human lymphocyte antigen Cw6 (HLACw6) does not predict treatment response to TNF-a inhibitors. 13th EADV Spring Symposium .19-22 May 2016
  1. INFLIXIMAB:ADVERSE EVENTS AS REASON FOR TREATMENT DISCONTINUATION.PSORIASIS 2016.PARIS 2016
  1. TREATMENT RESPONSE TO BIOLOGIC AGENTS IN PSORIATIC PATIENTS WITH OR NOT PSORIATIC ARTHRITIS. PSORIASIS 2016.PARIS 2016
  1. Epidemiological characteristics in patients with vitiligo in Greece: focusing on halo nevi and Koebner phenomenon.25th EADV Congress 2016
  1. Comorbidities of psoriasis such as psoriatic arthritis and metabolic syndrome do not affect the response to biologic agents.14th EADV spring symposium 25-28 May 2017 Brussels Belgium.
  1. Remission of symptoms of vesicular stomatitis in patients suffering from hidradenitis suppurativa after treatment with adalimumab. National Dermatology Congress .Thessaloniki 2017
  1. Hidradenitis suppurativa and genetic backround. National Dermatology Congress .Thessaloniki 2017
  1. Is there a connection between hidradenitis suppurativa and thrombophilia or just a random coexistence? National Dermatology Congress .Thessaloniki 2017
  1. EADV Resident course Pregnancy Dermatology . Dubrovnik,Croatia 2017(Βραβείο καλύτερης παρουσίασης).